Autopsy report · NCT02598479

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer

“The IRB which was overseeing the study stopped overseeing it”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Best Answer for Cancer Foundation

Sponsor type

University, hospital or other

Conditions

Cancer

Interventions

IPTLD and nutrition therapy

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• RCT Investigating Pre-cesarean Vaginal Wash of Chlorhexidine vs Povidone-iodine for Patient With Ruptured Amniotic Membrane.
  “The study was withdrawn from the IRB” (85% match in meaning)
• Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
  “Study halted prematurely; IRB approval not obtained” (82% match in meaning)
• Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
  “Study did not receive IRB approval, so did not start” (80% match in meaning)
• Antibiotics and Tissue Expanders in Breast Reconstruction
  “The study was withdrawn prior to IRB approval.” (80% match in meaning)
• Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue
  “IRB ended and NIH study ended” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.